Skip to main content
Premium Trial:

Request an Annual Quote

BCW Index Posts 2.8 Percent Gain

The BCW Index, led by strong gains for two of its components, finished the trading week ended Tuesday up 2.8 percent. Beckman Coulter and Molecular Devices led the way, posting double-digit gains for the week. Beckman, whose shares were upgraded last week by investment bank Bear Stearns to "outperform" from "peer perform," rose 11 percent for the tracking period, while Molecular Devices gained 12.4 percent on no news at all.

Only four of the 16 firms in the Index lost value during the week, led by Qiagen, which dropped 1.9 percent.

Overall, the Index beat out the Dow Jones Industrial Average, which closed the period up 1.3 percent, while the Nasdaq gained 2.7 percent, and the Nasdaq Biotech Index rose 3.9 percent.

BioCommerce Week Index of Diversified Molecular Biology Tool Companies
Company
Ticker
Current Price
(Nov. 8, 2005)
Last Price
(Nov. 1, 2005)
% change
Agilent
A
32.97
32.13
2.61
Applied Biosystems
ABI
25.23
24.97
1.04
Beckman
BEC
54.94
49.5
10.99
Bio-Rad
BIO
58.87
57.26
2.81
Bruker
BRKR
4.42
4.11
7.54
Fisher Scientific
FSH
57.1
56.64
0.81
GE
GE
33.76
33.6
0.48
Harvard Bio
HBIO
3.34
3.17
5.36
Invitrogen
IVGN
63.39
63.47
-0.13
Molecular Devices
MDCC
25.75
22.91
12.40
PerkinElmer
PKI
21.84
22.1
-1.18
Qiagen
QGEN
11.69
11.92
-1.93
Sigma
SIAL
64.61
64.06
0.86
Stratagene
STGN
9.95
9.69
2.68
Thermo
TMO
29.64
29.75
-0.37
Waters
WAT
38.73
36.51
6.08
BCW Index Average
33.51
32.61
2.77
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.